DocGo Inc. (NASDAQ:DCGO – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $2.38.
Several research analysts recently weighed in on the stock. Canaccord Genuity Group reissued a “hold” rating and set a $1.00 price objective on shares of DocGo in a research note on Tuesday, August 18th. Needham & Company LLC reaffirmed a “buy” rating and issued a $3.00 target price on shares of DocGo in a research note on Tuesday, August 18th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research note on Monday, September 14th.
Check Out Our Latest Research Report on DCGO
DocGo Trading Up 6.0%
DocGo (NASDAQ:DCGO – Get Free Report) last issued its earnings results on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The company had revenue of $73.42 million for the quarter, compared to the consensus estimate of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. Sell-side analysts predict that DocGo will post -0.22 earnings per share for the current year.
Hedge Funds Weigh In On DocGo
Institutional investors and hedge funds have recently made changes to their positions in the company. S Squared Technology LLC acquired a new stake in DocGo during the 2nd quarter worth $1,060,725. Renaissance Technologies LLC lifted its holdings in DocGo by 167.1% during the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after acquiring an additional 944,826 shares in the last quarter. BlackRock Inc. acquired a new position in DocGo in the second quarter valued at about $750,000. Isthmus Partners LLC grew its stake in DocGo by 14.0% in the first quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock valued at $637,000 after acquiring an additional 124,211 shares during the period. Finally, GSA Capital Partners LLP bought a new stake in shares of DocGo in the second quarter worth about $517,000. Institutional investors and hedge funds own 56.44% of the company’s stock.
About DocGo
DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.
The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.
Featured Stories
- Five stocks we like better than DocGo
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
